Clinical Trial Update: Fecal biOmarker Response Evaluation for Super-Early Efficacy in Ulcerative Colitis

View source ↗

Summary

Clinical trial update on a biomarker-based, super-early efficacy study in ulcerative colitis; the trial is not yet recruiting and involves fecal calprotectin an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Ulcerative Colitis (UC), Fecal Calprotetin | Status: NOT_YET_RECRUITING